Related Experiment Videos
Modulation of phorbol ester-induced HL-60 differentiation by prostaglandin E2
S D Dertinger1, D K Torous, A M Tometsko
1Litron Laboratories, Rochester, NY 14620, USA.
Mutation Research
|April 1, 1995
Summary
This study shows that Prostaglandin E2 (PGE2) enhances phorbol ester-induced HL-60 cell differentiation, a key indicator of tumor promotion. This flow cytometry assay can detect co-promoters involved in carcinogenesis.
Area of Science:
- Cell Biology
- Carcinogenesis Research
- Biochemistry
Background:
- HL-60 cells differentiate into phagocytic cells when exposed to phorbol tumor promoters.
- Flow cytometry quantifies differentiation by measuring fluorescent particle uptake in phagocytic cells (phag+).
- Tumor promotion involves agents that enhance carcinogen activity.
Purpose of the Study:
- To evaluate a flow cytometry-based HL-60 differentiation assay for detecting tumor promotion co-promoters.
- To assess the sensitivity of the assay to co-promoters that potentiate tumor promoter activity.
- To investigate the effect of Prostaglandin E2 (PGE2) as a model co-promoter on HL-60 cell differentiation.
Main Methods:
- HL-60 cells were treated with 12-O-tetradecanoyl phorbol-13-acetate (TPA) and varying concentrations of PGE2.
- Cell differentiation was assessed by measuring phagocytic activity using fluorescent particle uptake.
- Quantitative analysis of phag+ cells was performed using flow cytometry.
Main Results:
- PGE2 dose-dependently enhanced TPA-induced differentiation of HL-60 cells.
- The potentiating effect of PGE2 was maximal when administered before TPA, mirroring in vivo co-promotion.
- HL-60 cells demonstrated sensitivity to both phorbol promoters and the co-promoter PGE2.
Conclusions:
- The flow cytometry-based HL-60 differentiation assay is sensitive to co-promoters like PGE2.
- This assay system shows promise for studying agents involved in the tumor promotion phase of carcinogenesis.
- The findings support the utility of this assay for identifying chemical agents and cellular factors in tumor promotion.